Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 55 INDUSTRY 26 NIH 13 OTHER_GOV 1 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Cryotherapy 2 stenoparib 1 relugolix 1 nilutamide 1 histrelin 1 enzalutamide 1 capivasertib 1 bicalutamide 1 apalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abiraterone 1 Triptorelin Pamoate 1 Temozolomide 1 Surveys and Questionnaires 1 Prednisone 1 PM 01183 1 Nutritional Status 1 Methylprednisolone 1 Leuprolide 1 Hydroxychloroquine 1 Goserelin 1 Golytely 1 Flutamide 1 Exercise 1 Ethiodized Oil 1 Endoscopy, Digestive System 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Cystoscopy 1 Cryosurgery 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Temozolomide × 90 days × Clear all

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡